Cervical Cancers Escaping HPV Screening: Decoding HPV-Independent Carcinogenesis through Multi-Omics Profiling
Sector: Road • Location: Sweden
Source: EU Funding & Tenders Portal
Cervical cancer prevention assumes that most cases are caused by persistent infection with high-risk human papillomavirus (HPV). Yet 7 to 10 percent of invasive cervical cancers are HPV-negative, making them invisible to HPV-based screening and unaffected by vaccination; these cancers are often detected late and have worse outcomes. This project will define the biology of HPV-independent cervical
- Status
- Prospective
- Sector
- Road
- Location
- Sweden
- Updated
- 19 Nov 2026
- Source
- EU Funding & Tenders Portal
ConstructChat
Ask ConstructChat about Cervical Cancers Escaping HPV Screening: Decoding HPV-Independent Carcinogenesis through Multi-Omics Profiling
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | forthcoming |
Taiyo status | Prospective |
Taiyo last update | 2026-11-19 |
Contact
| Not available for this record. |
Description
Description | Cervical cancer prevention assumes that most cases are caused by persistent infection with high-risk human papillomavirus (HPV). Yet 7 to 10 percent of invasive cervical cancers are HPV-negative, making them invisible to HPV-based screening and unaffected by vaccination; these cancers are often detected late and have worse outcomes. This project will define the biology of HPV-independent cervical cancer and enable improved detection. I will lead a Nordic collaboration to assemble, to our knowledge, the largest rigorously confirmed cohort of HPV-negative cancers with matched HPV-positive controls, link them to nationwide registries, and apply an integrated multi-omics strategy (whole-exome DNA sequencing, RNA sequencing, and DNA methylation profiling) to map genomic, transcriptomic, and epigenomic trajectories. Crucially, I will test the hit-and-run hypothesis by reanalyzing earlier screening samples from the same women retrieved from national biobanks. From these data, I will develop and validate clinically actionable biomarkers with a clear path to implementation, and pilot their integration into confirmatory testing and national screening audits. The outcome will be a population-based molecular taxonomy of HPV-independent cervical cancer and a route to earlier detection for women whose cancers escape the HPV paradigm, directly supporting the World Health Organization’s cervical cancer elimination strategy and strengthening European screening practice. |
Location
Country | Sweden |
Source
Source | EU Funding & Tenders Portal |
URL |
More Details
Record type | Project |
Sector | Road |
Article published date | 2026-10-01 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
